Stockreport

Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease [Yahoo! Finance]

Sol-Gel Technologies Ltd. - Ordinary Shares  (SLGL) 
Last sol-gel technologies ltd. - ordinary shares earnings: 11/13 07:05 am Check Earnings Report
PDF patients with rare and severe skin conditions, today provided an update following the unblinding of clinical data from its vehicle-controlled proof-of-concept Phase 1b s [Read more]